参考文献/References:
[1]Jemal A, Bray F, Center MM, et al. Global cancer statistics [J]. CA Cancer J Clin, 2011, 61 (2): 69-90.
[2]CHEN Qi, Tong M, GUO Fang, et al. Parity correlates with the timing of developing endometrial cancer, but not subtype of endometrial cancer [J]. J Cancer, 2015, 6 (11): 1087-1092.
[3]Banno K, Yanokura M, Iida M, et al. Carcinogenic mechanisms of endometrial cancer: Involvement of genetics and epigenetics [J]. Journal of Obstetrics and Gynaecology Research, 2014, 40 (8): 1957-1967.
[4]Brown SB, Hankinson SE. Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers [J]. Steroids, 2015, 99 (Pt A): 8-10.
[5]Kuiper G, Enmark E, Pelto-Huikko M, et al. Duality of estrogen receptor β action in cancer progression [J]. Curr Opin Pharmacol, 2018, 41 (9): 66-73.
[6]Sandrin-Garcia P, Abramides DV, Martelli LR, et al. Typical phenotypic spectrum of velocardiofacial syndrome occurs independently of deletion size in chromosome 22q11.2 [J]. Mol Cell Biochem, 2007, 303 (1/2): 9-17.
[7]Wedrén S, Lovmar L, Humphreys K, et al. Estrogen receptor alpha gene polymorphism and endometrial cancer risk——a case-control study [J]. BMC Cancer, 2008, 8 (8): 322.
[8]ZHOU Xin, GU Yang, WANG Ding-ning, et al. Eight functional polymorphisms in the estrogen receptor 1 gene and endometrial cancer risk: a meta-analysis [J]. PLoS One, 2013, 8 (4): e60851.
[9]Nilsson S, Koehler KF, Gustafsson J. Development of subtype-selective oestrogen receptor-based therapeutics [J]. Nat Rev Drug Discov, 2011, 10 (10): 778-792.
[10]Abbasi S, Nouri M, Azimi C. Estrogen receptor genes variations and breast cancer risk in Iran [J]. Int J Clin Exp Med, 2012, 5 (4): 332-341.
[11]CHANG Huai-lu, Cheng YJ, Su CK, et al. Association of estrogen receptor α gene PvuII and XbaI polymorphisms with non-small cell lung cancer [J]. Oncol Lett, 2012, 3 (2): 462-468.
[12]LI Y, LIU F, TAN S-q, et al. Estrogen receptor-alpha gene PvuII(T/C)and XbaI(A/G)polymorphisms and endometriosis risk:a meta-analysis [J]. Gene, 2012, 508 (1): 41-48.
[13]Setiawan VW, Hankinson SE, Colditz GA, et al. Estrogen receptor beta (ESR2) polymorphisms and endometrial cancer (United States) [J]. Cancer Causes Control, 2004, 15 (6): 627-633.
[14]Lattrich C, Hring J, Schüler S, et al. Polymorphisms in the promoter region of estrogen receptor β gene in endometrial cancer [J]. Arch Gynecol Obstet, 2014, 289 (3): 631-635.
相似文献/References:
[1]李成龙,冷金花.子宫内膜异位症与雌、孕激素受体关系的研究进展[J].中国计划生育和妇产科,2010,(04):0.
[2]李金皎,段华.G蛋白偶联雌激素受体对细胞增殖调节的研究进展[J].中国计划生育和妇产科,2016,(02):0.
[3]宋昭逸,王晶晶,时青云,等.雌激素受体α对胆汁酸转运相关基因的调控及其与孕鼠肝内胆汁淤积症发生的相关性[J].中国计划生育和妇产科,2016,(10):0.
SONG Zhao-yi,WANG Jing -jing,SHI Qing-yun,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(1):0.
[4]赵淑芬*,柳怡,郑雪湘.宫腔粘连患者子宫内膜组织中雌激素受体及孕激素受体的表达情况和临床意义分析[J].中国计划生育和妇产科,2018,(7):33.
ZHAO Shu-fen*,LIU Yi,ZHENG Xue-xiang.Expression and clinical significance of ER and PR in endometrial tissue of patients with intrauterine adhesion[J].Chinese Journal of Family Planning & Gynecotokology,2018,(1):33.